Chapter 1. SAFETY SYRINGES MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. SAFETY SYRINGES MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. SAFETY SYRINGES MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. SAFETY SYRINGES MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. SAFETY SYRINGES MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. SAFETY SYRINGES MARKET– By Technology

6.1. Retractable Safety Syringes

       6.1.1. Automatic Retractable Safety Syringes

       6.1.2. Manual Retractable Safety Syringes

6.2. Non-Retractable Safety Syringes

       6.2.1. Sheathing Tube Syringes

       6.2.2. Sliding Needle Cover Syringes

       6.2.3. Hinged Needle Cover Syringes

Chapter 7. SAFETY SYRINGES MARKET– By Therapy

7.1. Insulin

7.2. Glucagon-like peptide-1 (GLP-1)

7.3. Tuberculosis

7.4. Growth Hormones

Chapter 8. SAFETY SYRINGES MARKET– By End User

8.1. Home care

8.2. Hospitals

Chapter 9. SAFETY SYRINGES MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. SAFETY SYRINGES MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10